title: Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.
abstract: Injection of low doses of particulate hepatitis B surface Ag (HBsAg) into H-2d mice without adjuvants primes an Ld-restricted, S28-39-specific T cell response. This study indicates that dendritic cells (DC) and macrophages (M phi) both serve as APCs that support priming of CD8+ CTL precursors in vivo to exogenous HBsAg particles. After transfer into a syngeneic, naive host, HBsAg particle-pulsed DC, either freshly purified from skin or derived from a cloned DC line, efficiently primed class I-restricted, HBsAg-specific CTL precursors. M phi, either harvested from the peritoneal cavity or generated in macrophage-CSF-stimulated bone marrow cell cultures in vitro or derived from established, cloned M phi lines (PU5-1.8, J774A.1), pulsed with HBsAg particles in vivo or in vitro, elicited a class I-restricted, HBsAg-specific CTL response after adoptive transfer into naive hosts. The class I-restricted CTL response induced by HBsAg particle immunization was suppressed in carrageenan-treated mice, but was restored when carrageenan-treated mice were immunized with syngeneic, HBsAg-pulsed M phi. Selective elimination of M phi by liposome-incorporated dichloromethylene-diphosphonat did not suppress the induction of a CTL response of H-2d mice by HBsAg particle immunization. HBsAg-pulsed, freshly prepared DC are more potent than pulsed M phi in priming class I-restricted CTL in vivo. The relative importance of both types of APC in priming CTL remains to be resolved.
authors.affiliation: Institute for Medical Microbiology, University of Ulm, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Böhm
authors.forename: R
authors.initials: R
authors.lastname: Schirmbeck
authors.forename: A
authors.initials: A
authors.lastname: Elbe
authors.forename: K
authors.initials: K
authors.lastname: Melber
authors.forename: D
authors.initials: D
authors.lastname: Diminky
authors.forename: G
authors.initials: G
authors.lastname: Kraal
authors.forename: N
authors.initials: N
authors.lastname: van Rooijen
authors.forename: Y
authors.initials: Y
authors.lastname: Barenholz
authors.forename: J
authors.initials: J
authors.lastname: Reimann
mesh_terms: D000818:Animals; D017951:Antigen Presentation; D001853:Bone Marrow / Q000276:immunology*; D001854:Bone Marrow Cells; D002999:Clone Cells; D003713:Dendritic Cells / Q000276:immunology*; D006511:Hepatitis B Antigens / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D016219:Immunotherapy, Adoptive; D008264:Macrophages / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D013602:T-Lymphocytes, Cytotoxic / Q000166:cytology / Q000276:immunology*
chemical_list: D006511:Hepatitis B Antigens; D015395:Histocompatibility Antigens Class I